Minimal Invasive Transforaminal Lumbar Interbody Fusion for Degenerative Lumbar and Lumbosacral Spine Diseases

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorSohag University

About this trial

The aim of this study is to evaluate clinical and surgical outcome of MI-TLIF for degenerative lumbar and lumbosacral spine diseases.

Eligibility criteria

Qualifiers

Degenerative spondylolisthesis.

Degenerative unilateral disc herniations.

Recurrent disc herniation.

Disqualifiers

Spondylolisthesis Grade III or IV.

Degenerative scoliosis .

Traumatic fracture spine.

Infections.

Trial design

Treatments tested in this trial

  • lumbar fusion

Treatment groups

No treatment groups listed

Locations

This trial has no locations

Sponsors and collaborators